Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyCongenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epileptic Syndromes, Hippocampal Sclerosis, Malformations of Cortical Development, Group I, brain disorder, central nervous system disorder, central nervous system malformation, cerebral cortical dysplasia, epilepsy, nervous system disorderRecruitingPhase 1 / Phase 22026-08-24NCT06063850

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
UniQure Biopharma B.V.5

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Allegheny Health NetworkPittsburghUnited States35
Baylor Scott & White Medical CenterAustinUnited States1
Cleveland ClinicClevelandUnited States558
Corewell HealthGrand RapidsUnited States45
Dartmouth Hitchcock Medical CenterLebanonUnited States79
Hospital of the University of PennsylvaniaPhiladelphiaUnited States142
Johns Hopkins School of MedicineBaltimoreUnited States21
Kansas University Medical CenterKansas CityUnited States25
Massachusetts General HospitalBostonUnited States1015
Mayo Clinic ArizonaPhoenixUnited States55
Mayo Clinic FloridaJacksonvilleUnited States105
Medical College of WisconsinMilwaukeeUnited States483
Midatlantic Epilepsy and Sleep CenterBethesdaUnited States1
Northeast Regional Epilepsy GroupHackensackUnited States10
Ohio State UniversityColumbusUnited States169
Robert Wood Johnson HospitalNew BrunswickUnited States1
Stanford UniversityPalo AltoUnited States161
University of Alabama at BirminghamBirminghamUnited States1